Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 123 publications.

Anthony MS. Soy and cardiovascular disease and other potential health effects. Presented at the Iowa Soybean Promotion Board; December 8, 1999. New York, NY.

Garcia Rodriguez LA, Duque A, Castellsague J, Perez-Gutthann S, Stricker BH. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol. 1999 Dec 1;48(6):847-52.

Yang J, Cullen BR. Structural and functional analysis of the avian leukemia virus constitutive transport element. RNA. 1999 Dec;5:1645-55.

Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry. 1999 Dec;175:575-80. doi: 10.1192/bjp.175.6.576

Rasouliyan L, Gibson W. Construction of "helper" cell line for mutants of cytomegalovirus. Poster presented at the Johns Hopkins Medical Institutions, Department of Pharmacology and Molecular Sciences Rotation Presentations; December 1999. Baltimore, MD.

Dreyer NA, Loughlin JE, Rothman KJ. Cause-specific mortality in cellular telephone users. JAMA. 1999 Nov 17;282(19):1814-6. doi: 10-1001/pubs.JAMA-ISSN-0098-7484-282-19-jbk1117.

Yang J, Bogerd HP, Peng S, Wiegand H, Truant R, Cullen BR. An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13404-8.

Ennett ST, Bauman K, Foshee VA, Pemberton M, Hicks KA. Family communication about adolescent tobacco and alcohol use. Presented at the American Public Health Association annual meeting; November 1999.

Cohen LM, Britt DM, Collins FL, Stott HD, Carter LC. Chewing gum affects smoking topography. Exp Clin Psychopharmacol. 1999 Nov 1;7(4):444-7.

McKenna SP, Whalley D. Assessment of biotechnology drugs: what are the issues? Letter to the editor. Health Policy (New York). 1999 Nov;49(3):195-7. doi: 10.1016/S0168-8510(99)00055-X

Whalley D, Doward LC, Dewar Al, McKenna SP, Tennant A, Emery P. The development of a quality of life measure specific to psoriatic arthritis. Poster presented at the 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL); November 1999. Barcelona, Spain. [abstract] Qual Life Res. 1999 Nov; 8(7):652.

Doward LC, Whalley D, Dewar Al, McKenna SP, Tennant A, Emery P. The development of the SLE-QoL: a quality of life instrument specific to systemic lupus erythematosus. Poster presented at the 6th Annual Conference of the International Society for Quality of Life Research (ISOQOL); November 1999. Barcelona, Spain. [abstract] Qual Life Res. 1999 Nov; 8(7):609.

Rothman KJ. A proposal to calculate publication equivalents. Epidemiology. 1999 Nov;10(6):664-5.

Hauber AB. Potential savings in the cost of caring for alzheimer's disease: patient treatment with rivastigmine. Presented at the Annual Meetings of the Gerontological Society of America; November 1999. Previously presented at the Annual Meetings of International Society of Pharmacoeconomics and Outcomes Research.

Neighbors DM. Potential for bias when using clinical trial adverse event rates to estimate toxicity costs. Presented at the 1999 ISPOR 2nd Annual European Congress; November 1999. Edinburgh, Scotland.

Neighbors DM, Downs KE. Medical resource use data collection in clinical trials. Presented at the DIA Meeting Session Economic Assessment in Clinical Trials: Design and Analysis; November 1999. Orlando, FL.

Olshan AF, Smith J, Cook MN, Grufferman S, Pollock BH, Stram DO, Seeger RC, Look AT, Cohn SL, Castleberry RP, Bondy ML. Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. Am J Epidemiol. 1999 Nov 1;150(9):930-8.

Mansfield CA, Smith VK. Trade-offs at the trough: balancing costs and benefits. Presented at the Annual Meeting of the Southern Economic Association; November 1999.

Anthony MS. Soy: a potential postmenopausal therapy. Presented at the American Public Health Association 127th Annual Meeting and Exposition; November 1999. Chicago, IL.

Kusne S, Grossi P, Irish W, St George K, Rinaldo C, Rakela J, Fung J. Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation. 1999 Oct 27;68(8):1125-31.

Williams VSL. Exploring statistical adjustment of results from the National Assessment of Educational Progress (Technical Report #102). 1999. Research Triangle Park, NC. National Institute of Statistical Sciences.

Girman CJ, Hartmaier S, Roberts J, Bergeld W, Waldstreicher J. Patient-perceived importance of negative effects of androgenetic alopecia in women. J Womens Health Gend Based Med. 1999 Oct;8(8):1091-5. doi: 10.1089/jwh.1.1999.8.1091

McKenna SP, Doward LC. A review of quality of life in Alzheimer's disease. Parts 1 and 2: issues in assessing disease impact and drug effects. Pharmacoeconomics. 1999 Oct;16(4):417-9.

Castellsague J, Garcia-Rodriguez LA, Perez-Gutthann S, Agostinis L, Cattaruzi C, Troncon MG. Characteristics of users of inhaled long-acting beta 2-agonists in a southern European population. Respir Med. 1999 Oct 1;93(10):709-14.

Walker AM, Szneke P, Weatherby LB, Dicker LW, Lanza LL, Loughlin JE, Yee CL, Dreyer NA. The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada. Am J Med. 1999 Oct 1;107(4):356-62.

Anthony MS. Soy and cardiovascular disease: cholesterol lowering and beyond. Presented at the 3rd International Symposium on the Role of Soy in Preventing and Treating Chronic Disease; October 1999. Washington, DC.

Anthony MS. Soy and cardiovascular disease: potential health benefits. Presented at the 6th National Scientific Sessions of the Consortium for Southeastern Hypertension Control; October 1999. San Juan, Puerto Rico.

Enger C, Rothman KJ, Kylstra JW. Mortality rates during two years of treatment with intermittent inhaled tobramycin (TOBI) in cystic fibrosis. Pediatr Pulmonol. 1999 Sep 22;28(Suppl 19):339-40.

Kang Y, Bogerd HP, Yang J, Cullen BR. Analysis of the RNA binding specificity of the human tap protein, a constitutive transport element-specific nuclear RNA export factor. Virol J. 1999 Sep 15;262(1):200-9. doi: 10.1006/viro.1999.9906

Camilleri M, Mayer EA, Drossman DA, Heath AT, Dukes GE, McSorley DJ, Kong S, Mangel AW, Northcutt AR. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther. 1999 Sep;13(9):1149-59.

Niaura R, Britt DM, Borrelli B, Shadel WG, Abrams DB, Goldstein MG. History and symptoms of depression among smokers during a self-initiated quit attempt. Nicotine Tob Res. 1999 Sep 1;1(3):251-7.

Sorensen HT, Steffensen FH, Olsen J, Sabroe S, Gillman MW, Rothman KJ, Fischer P. Long-term follow-up of cognitive outcome after breech presentation at birth. Epidemiology. 1999 Sep 1;10(5):554-6.

Hoffman E. Within cluster resampling. Presented at the Gertrude M. Cox building dedication at Research Triangle Institute; September 1999. Research Triangle Park, NC. Previously presented at the 1998 ENAR Conference.

Siami G, Christou N, Eiseman I, Carter CM, Tack K. A randomized study of clinafloxacin and piperacillin/tazobactam in severe skin and soft tissue infections. Poster presented at the 39th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1999.

Helliwell PS, Doward L, Whalley D, Tennant A, McKenna S, Reynolds S, Kay L, Spoorenberg A, van der Heijde Leeds D. Psychometric and scaling properties of a new quality of life instrument specific to ankylosing spondylitis (AS). Poster presented at the 1999 ACR/ARHP Annual Scientific Meeting; November 14, 1999. Boston, MA. [abstract] Arthritis Rheumatol. 1999 Sep; 42(S9):s72.

Anthony MS. The usefulness of clinical trials: examples from soy and isoflavone research. Presented at the Developing breakthroughs in science and technology. Sponsored by Banner Pharmacaps; September 1999. Winston-Salem, NC.

McKenna SP, Whalley D, Renck-Hooper U, Carlin S, Doward LC. The development of a quality of life instrument for use with post-menopausal women with urogenital atrophy in the UK and Sweden. Qual Life Res. 1999 Aug;8(5):393-8.

Canafax DM, Irish WD, Moran HB, Squiers E, Levy R, Pouletty P, First MR, Christians U. An individual bioequivalence approach to compare the intrasubject variability of two cyclosproine formulations, SangCya and Neoral. Pharmacology. 1999 Aug 1;59(2):78-88.

Lorente A, Fernandez-Saiz M, Herraiz F, Lehn JM, Vigneron JP. Photocleavage of DNA by tetracationic intercalands containing phenazine and viologen subunits. Tetrahedron Lett. 1999 Aug 1;40(32):5901-4.

Anthony MS. Soy and CHD. Presented at the World Soybean Research Conference VI; August 1999. Chicago, IL.

Andrews EB. Data privacy, medical record confidentiality, and research in the interest of public health. Pharmacoepidemiol Drug Saf. 1999 Jul 1;8(4):247-60.

Stull DE, Starling R, Haas G, Young JB. Becoming a patient with heart failure. Heart Lung. 1999 Jul;28(4):284-92.

Mauskopf J. Modeling of annual treatment costs and health outcomes of antipsychotic agents for schizophrenic populations. Am J Manag Care. 1999 Jul 1;5(No. 10 Suppl):S601-11.

Perez-Gutthann S, Garcia-Rodriguez LA, Duque-Oliart A, Varas-Lorenzo C. Low-dose diclofenac, naproxen, and ibuprofen cohort study. Pharmacotherapy. 1999 Jul 1;19(7):854-9. doi: 10.1592/phco.19.10.854.31550

McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L, Wiren L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res. 1999 Jun;8(4):373-83.

Yates ME, Stellato RK, Johannes CB, Avis NE. The importance of AIDS-related knowledge for mid-life and older women. AIDS Educ Prev. 1999 Jun;11(3):224-31.

Dreyer NA, Loughlin JE, Rothman KJ. Epidemiologic safety surveillance of cellular telephones in the US. Radiat Prot Dosimetry. 1999 Jun;83(1):159-63.

Crawford SL, Johannes CB. The epidemiology of cardiovascular disease in postmenopausal women. J Clin Endocrinol Metab. 1999 Jun 1;84(6):1803-5. doi: 10.1210/jcem.84.6.5765-4

Schwartz HI, Perschy TB, McSorley DJ, Sorrells SC. Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori. Am J Gastroenterol. 1999 Jun;4(2):121-7.

Anderson JJB, Anthony M, Messina M, Garner SC. Effects of phyto-oestrogens on tissues. Nutr Res Rev. 1999 Jun;12(01):75-116.